SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Open accessPublished version of a preprint
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antibody detection of prior SARS-CoV-2 infection depends on severity, assay, and timing with implications for serosurveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 1×
“Participants were questioned regarding the presence, duration (in days), and current status of a list of COVID-19 symptoms and additional somatic symptoms derived from the Patient Health Questionnaire (21), as well as measures of quality of life derived from the EQ-5D-5L Instrument (22).”
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674 · cited 1×
“These two assays, along with a research-use assay using direct detection (RBD-LIPS), were the only ones to demonstrate increasing rather than decreasing antibody signal over time, possibly due to continued affinity maturation of the antibody response (18) playing a larger role in detection with this format.”
MethodSeow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Cited by
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Ely, E. W., Brown, L. M., & Fineberg, H. V. (2024) · New England Journal of Medicine · doi:10.1056/nejmsb2408466 · Cited by 340
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 320
Self-citationBarber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298
Jones, J. M., Stone, M., Sulaeman, H., Fink, R. V., Dave, H., Levy, M. E., Di Germanio, C., Green, V., Notari, E., Saa, P., et al. (2021) · JAMA · doi:10.1001/jama.2021.15161 · Cited by 201
Self-citationPeluso, M. J., Kelly, J. D., Lu, S., Goldberg, S. A., Davidson, M. C., Mathur, S., Durstenfeld, M. S., Spinelli, M. A., Hoh, R., Tai, V., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab640 · Cited by 135
Self-citationTzou, P. L., Tao, K., Pond, S. L. K., & Shafer, R. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261045 · Cited by 130
SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19
Peluso, M. J., Deeks, S. G., Mustapić, M., Kapogiannis, D., Henrich, T. J., Lu, S., Goldberg, S. A., Hoh, R., Chen, J. Y., Martinez, E. O., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26350 · Cited by 119
Self-citationContribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
Chen, L.-L., Abdullah, S. M. U., Chan, W.-M., Chan, B. P.-C., Ip, J. D., Chu, A. W.-H., Lu, L., Zhang, X., Zhao, Y., Chuang, V. W.-M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31395-0 · Cited by 72
Peluso, M. J., Spinelli, M. A., Deveau, T., Forman, C. A., Munter, S. E., Mathur, S., Tang, A. F., Lu, S., Goldberg, S. A., Arreguin, M. I., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003338 · Cited by 67
Self-citationPelleau, S., Woudenberg, T., Rosado, J., Donnadieu, F., García, L., Obadia, T., Gardais, S., Elgharbawy, Y., Velay, A., Gonzalez, M., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab375 · Cited by 65
Barrie, M. B., Lakoh, S., Kelly, J. D., Kanu, J. S., Squire, J. S., Koroma, Z., Bah, S., Sankoh, O. A., Brima, A. S., Ansumana, R., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-007271 · Cited by 63
Self-citationStone, M., Grebe, E., Sulaeman, H., Germanio, C. D., Dave, H., Kelly, K. K., Biggerstaff, B. J., Crews, B. O., Tran, N. K., Jerome, K. R., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2803.211885 · Cited by 62
Self-citationSun, K., Tempia, S., Kleynhans, J., von Gottberg, A., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., du Plessis, M., Carrim, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7081 · Cited by 52
Brazeau, N. F., Verity, R., Jenks, S. J., Fu, H., Whittaker, C., Winskill, P., Dorigatti, I., Walker, P. G. T., Riley, S., Schnekenberg, R. P., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00106-7 · Cited by 60
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser‐Nobis, K., Filomena, A., Mahler, V., Maier, T. J., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.105052 · Cited by 56
Germanio, C. D., Simmons, G., Kelly, K. K., Martinelli, R., Darst, O., Azimpouran, M., Stone, M., Hazegh, K. E., Grebe, E., Zhang, S., et al. (2021) · Transfusion · doi:10.1111/trf.16555 · Cited by 44
Self-citationAdapting Serosurveys for the SARS-CoV-2 Vaccine Era
Duarte, N., Yanes‐Lane, M., Arora, R. K., Bobrovitz, N., Liu, M., Bego, M. G., Yan, T., Cao, C., Gurry, C., Hankins, C. A., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab632 · Cited by 46
Stone, M., Germanio, C. D., Wright, D. J., Sulaeman, H., Dave, H., Fink, R. V., Notari, E. P., Green, V., Strauss, D., Kessler, D., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab537 · Cited by 45
Self-citationCOVID ‐19 and plasma cells: Is there long‐lived protection?*
Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 53
Cattaneo, C. M., Cancelli, V., Imberti, L., Dobbs, K., Sottini, A., Pagani, C., Belotti, A., Re, A., Anastasia, A., Quaresima, V., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00546-9 · Cited by 44
Self-citationLi, Z., Lewis, B. E., Berney, K., Hallisey, E. J., Williams, A. M., Whiteman, A., Rivera-González, L. O., Clarke, K. E. N., Clayton, H. B., Tincher, T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciac105 · Cited by 38
Self-citationReinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
Junior, C. A. P., Buss, L., Buccheri, R., Abrahim, C. M. M., Salomon, T., Crispim, M. A. E., Oikawa, M. K., Grebe, E., Costa, A. G., Fraiji, N. A., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07094-y · Cited by 43
Self-citationLudolf, F., Ramos, F. F., Bagno, F. F., Oliveira‐da‐Silva, J. A., Reis, T. A. R., Christodoulides, M., Vassallo, P. F., Ravetti, C. G., Junior, V. A. N., da Fonseca, F. G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn7424 · Cited by 35
Lu, L., Chen, L., Zhang, R., Tsang, O. T., Chan, J. M., Tam, A. R., Leung, W.-S., Chik, T. S., Lau, D. P.-L., Choi, C. Y.-C., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103986 · Cited by 31
Herman, J. D., Wang, C., Burke, J. S., Zur, Y., Compere, H., Kang, J., Macvicar, R., Taylor, S., Shin, S. A., Frank, I., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100811 · Cited by 36
Nicolete, V. C., Rodrigues, P. T., Johansen, I. C., Corder, R. M., Tonini, J., Cardoso, M. A., de Jesus, J. G., Claro, I. M., Faria, N. R., Sabino, É. C., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab410 · Cited by 40
Couture, A., Lyons, B. C., Mehrotra, M., Sosa, L. E., Ezike, N. O., Ahmed, F. S., Brown, C., Yendell, S. J., Azzam, I. A., Katić, B., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac044 · Cited by 30
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
Bottomley, C., Otiende, M., Uyoga, S. M., Gallagher, K. E., Kagucia, E. W., Etyang, A. O., Mugo, D., Gitonga, J. N., Karanja, H., Nyagwange, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26452-z · Cited by 31
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
Abdolmaleki, G., Taheri, M. A., Paridehpour, S., Mohammadi, N. M., Tabatabaei, Y. A., Mousavi, T., & Amin, M. (2022) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-022-00446-8 · Cited by 30
Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
Briggs, J. J., Takahashi, S., Nayebare, P., Cuu, G., Rek, J. C., Zedi, M., Kizza, T., Arinaitwe, E., Nankabirwa, J. I., Kamya, M. R., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55978 · Cited by 33
Self-citationPerez‐Saez, J., Zaballa, M.-E., Lamour, J., Yerly, S., Dubos, R., Courvoisier, D. S., Villers, J., Balavoine, J.-F., Pittet, D., Kherad, O., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38744-7 · Cited by 23
Wolter, N., Tempia, S., von Gottberg, A., Bhiman, J. N., Walaza, S., Kleynhans, J., Moyes, J., Buys, A., McMorrow, M., Aitken, S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciac198 · Cited by 28
Audu, R., Stafford, K. A., Steinhardt, L. C., Musa, A. Z., Iriemenam, N. C., Ilori, E. A., Blanco, N., Mitchell, A. B., Hamada, Y., Moloney, M., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000363 · Cited by 23
A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data
Ghafari, M., Watson, O. J., Karlinsky, A., Ferretti, L., & Katzourakis, A. (2022) · Nature Communications · doi:10.1038/s41467-022-30711-y · Cited by 22
MultiSero: An Open-Source Multiplex-ELISA Platform for Measuring Antibody Responses to Infection
Byrum, J. R., Waltari, E., Janson, O., Guo, S.-M., Folkesson, J., Chhun, B. B., Vinden, J., Ivanov, I. E., Forst, M. L., Li, H., et al. (2023) · Pathogens · doi:10.3390/pathogens12050671 · Cited by 18
Self-citationPeluso, M. J., Donatelli, J. L., & Henrich, T. J. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.006 · Cited by 20
Self-citationShah, M. M., Spencer, B. R., Feldstein, L. R., Haynes, J. M., Benoit, T. J., Saydah, S., Groenewold, M. R., Stramer, S. L., & Jones, J. M. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac883 · Cited by 18
Clarke, K. E. N., Kim, Y., Jones, J. M., Lee, A., Deng, Y., Nycz, E., Iachan, R., Gundlapalli, A. V., MacNeil, A., & Hall, A. J. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac423 · Cited by 17
Lijeskić, O., Klun, I., Djaković, M. S., Gligorić, N., Štajner, T., Srbljanović, J., & Djurković–Djaković, O. (2021) · Vaccines · doi:10.3390/vaccines9091031 · Cited by 17
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Owusu‐Boaitey, N., Russell, T., Meyerowitz‐Katz, G., Levin, A., & Herrera, D. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.21.2200809 · Cited by 16
COVID-19-associated neurological and psychological manifestations
Wilson, J. E., Gurdasani, D., Helbok, R., Ozturk, S., Fraser, D. D., Filipović, S. R., Peluso, M. J., Iwasaki, A., Yasuda, C. L., Bocci, T., et al. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00674-7 · Cited by 22
Self-citationMehrotra, M., Lim, E., Lamba, K., Kamali, A., Lai, K., Meza, E., Szeto, I., Robinson, P. V., Tsai, C., Gebhart, D., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac246 · Cited by 16
Nan, J., Sun, W., Liu, X., Che, Y., Shan, H., Yue, Y., Liu, J., Wang, L., Liu, K., Xu, W., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03732 · Cited by 15
Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021
Tunheim, G., Rø, G., Chopra, A., Aase, A., Kran, A. B., Vaage, J. T., Lund‐Johansen, F., & Hungnes, O. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13024 · Cited by 13
Mizoue, T., Yamamoto, S., Konishi, M., Oshiro, Y., Inamura, N., Nemoto, T., Ozeki, M., Horii, K., Okudera, K., Sugiyama, H., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.08.015 · Cited by 14
Wang, K., Wang, S., Margolis, S., Cho, J. M., Zhu, E., Dupuy, A., Yin, J., Park, S., Magyar, C. E., Adeyiga, O. B., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq6778 · Cited by 15
Samore, M. H., Looney, A., Orleans, B., Greene, T., Seegert, N., Delgado, J. C., Presson, A. P., Zhang, C., Ying, J., Zhang, Y., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2711.204435 · Cited by 14
Tjaden, A. H., Edelstein, S. L., Ahmed, N., Calamari, L., Dantuluri, K. L., Gibbs, M. A., Hinkelman, A. N., Mongraw‐Chaffin, M., Sanders, J. W., Saydah, S., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13080 · Cited by 14
Sawry, S., Roux, J. L., Wolter, N., Mbatha, P., Bhiman, J. N., Balkus, J. E., von Gottberg, A., Cohen, C., Chersich, M., Kekana, M., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.036 · Cited by 14
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2
Routledge, I., Takahashi, S., Epstein, A., Hakim, J. M. C., Janson, O., Turcios, K., Vinden, J., Risos, J. T., Baniqued, M. R., Pham, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30051-x · Cited by 11
Self-citationPlumb, I. D., Fette, L. M., Tjaden, A. H., Feldstein, L. R., Saydah, S., Ahmed, A., Link‐Gelles, R., Wierzba, T. F., Berry, A. A., Friedman-Klabanoff, D. J., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.03.006 · Cited by 12
Infection-associated chronic conditions: Why Long Covid is our best chance to untangle Osler’s web
Peluso, M. J., Hanson, M. R., & Deeks, S. G. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado2101 · Cited by 15
Self-citationTakahashi, S., Peluso, M. J., Hakim, J. M. C., Turcios, K., Janson, O., Routledge, I., Busch, M. P., Hoh, R., Tai, V., Kelly, J. D., et al. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad106 · Cited by 13
Self-citationBeck, E. J., Hsieh, Y., Fernández, R. E., Dashler, G., Egbert, E. R., Truelove, S. A., Garliss, C. C., Wang, R., Bloch, E. M., Shrestha, R., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-21 · Cited by 12
Campbell, H., & Gustafson, P. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821002405 · Cited by 11
O’Brien, S. C., Cole, L. D., Albanese, B. A., Mahon, A., Knight, V., Williams, N., Severson, R., Burakoff, A. W., Alden, N. B., & Dominguez, S. R. (2023) · Emerging infectious diseases · doi:10.3201/eid2905.221541 · Cited by 11
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over timePreprint
Gentles, L. E., Kehoe, L., Crawford, K. H. D., Lacombe, K., Dickerson, J. A., Wolf, C. R., Yuan, J., Schuler, S., Watson, J. T., Nyanseor, S., et al. (2022) · medRxiv · doi:10.1101/2022.01.14.22269235 · Cited by 11
Germanio, C. D., Deng, X., Balasko, B. G., Simmons, G., Martinelli, R., Grebe, E., Stone, M., Spencer, B. R., Saá, P., Yu, E. A., et al. (2024) · Transfusion · doi:10.1111/trf.18017 · Cited by 11
Self-citationSARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil
Chaves, D. G., Takahashi, R. H. C., Campelo, F., Malta, M. C. F. D. S., de Oliveira, I. R., Barbosa‐Stancioli, E. F., Ribeiro, M. A., & Martins, M. L. (2022) · Emerging infectious diseases · doi:10.3201/eid2804.211961 · Cited by 14
Goss, C. W., Maricque, B. B., Anwuri, V. V., Cohen, R. E., Donaldson, K., Johnson, K. J., Powderly, W. G., Schechtman, K. B., Schmidt, S., Thompson, J. J., et al. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2022.03.002 · Cited by 11
Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing
Burbelo, P. D., Ji, Y., & Iadarola, M. J. (2023) · Biosensors · doi:10.3390/bios13030303 · Cited by 13
Self-citationA Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, India
Hitchings, M. D. T., Patel, E. U., Khan, R. T., Srikrishnan, A. K., Anderson, M. G., Kumar, K. S., Wesolowski, A., Iqbal, H. S., Rodgers, M. A., Mehta, S. H., et al. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad103 · Cited by 10
Self-citationSevere Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in Blood Donor Populations
Patel, E. U., Bloch, E. M., & Tobian, A. A. R. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab517 · Cited by 9
SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021
Tran, T. N.-A., Wikle, N. B., Yang, F., Inam, H., Leighow, S. M., Gentilesco, B. J., Chan, P. A., Albert, E., Strong, E. R., Pritchard, J. R., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.14171 · Cited by 8
Castro, M. D. M., Caicedo-Holguín, I., Ortiz-Rojas, H. J., Castillo, C. M., Medina, A. G., Alexander, N. D. E., Gómez, M. A., & Albornóz, L. L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256566 · Cited by 11
Glasser, J. W., Feng, Z., Vo, M., Jones, J. N., & Clarke, K. E. N. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111296 · Cited by 8
Ma, X., Li, Z., Whelan, M. G., Kim, D., Cao, C., Yanes‐Lane, M., Yan, T., Jaenisch, T., Chu, M., Clifton, D. A., et al. (2022) · Vaccines · doi:10.3390/vaccines10122000 · Cited by 8
Buck, A. M., Deitchman, A. N., Takahashi, S., Lu, S., Goldberg, S. A., Bodansky, A., Kung, A., Hoh, R., Williams, M. C., Kerbleski, M. B., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29216 · Cited by 8
Self-citationTzou, P. L., Tao, K., Pond, S. L. K., & Shafer, R. W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.24.469823 · Cited by 8
Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents
Rothoeft, T., Maier, C., Talarico, A., Hoffmann, A., Schlegtendal, A., Lange, B., Petersmann, A., Denz, R., Timmesfeld, N., Toepfner, N., et al. (2024) · Infection · doi:10.1007/s15010-024-02225-w · Cited by 10
Macı́as, J., Fernández‐Fuertes, M., Oliver, N., Corma‐Gómez, A., Real, L. M., & Pineda, J. A. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.01.028 · Cited by 7
Stern, D., Meyer, T. C., Treindl, F., Mages, H. W., Krüger, M., Skiba, M., Krüger, J. P., Zobel, C., Schreiner, M., Grossegesse, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48581-9 · Cited by 9
Benoit, T., Kim, Y., Deng, Y.-Y., Li, Z., Harding, L., Wiegand, R., Deng, X.-Y., Jones, J. M., Ronaldo, I., & Clarke, K. (2024) · Public health reports (1974) · doi:10.1177/00333549231223140 · Cited by 7
Iwamoto, C., Lesteberg, K. E., Lamb, M. M., Calvimontes, D. M., Guo, K., Barrett, B. S., Mickens, K. L., Duca, L. M., Monzon, J. C., Chard, A. N., et al. (2022) · Vaccines · doi:10.3390/vaccines10071160 · Cited by 7
Vangeti, S., Periasamy, S., Sun, P., Balinsky, C. A., Mahajan, A. S., Kuzmina, N. A., Schanoski, A. S., Cooper, E. S., Beckett, C. G., Marayag, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01837-22 · Cited by 7
Petrović, V., Vuković, V., Patić, A., Marković, M., & Ristić, M. (2022) · Vaccines · doi:10.3390/vaccines11010056 · Cited by 7
García‐Carreras, B., Hitchings, M. D. T., Johansson, M. A., Biggerstaff, M., Slayton, R. B., Healy, J. M., Lessler, J., Quandelacy, T. M., Salje, H., Huang, A. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37944-5 · Cited by 6
Open-source milligram-scale, four channel, automated protein purification system
Puccinelli, R. R., Sama, S. S., Worthington, C. M., Puschnik, A. S., Pak, J. E., & Gómez-Sjöberg, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297879 · Cited by 6
Self-citationElledge, S. K., Eigl, I., Phelps, M., McClinton, K., Zhou, X. X., Leung, K., Tato, C. M., & Wells, J. A. (2022) · Current Protocols · doi:10.1002/cpz1.521 · Cited by 5
Self-citationTakahashi, S., Peluso, M. J., Hakim, J. M. C., Turcios, K., Janson, O., Routledge, I., Busch, M. P., Hoh, R., Tai, V., Kelly, J. D., et al. (2021) · medRxiv · doi:10.1101/2021.09.09.21263139 · Cited by 6
Self-citationBriggs, J. J., Takahashi, S., Nayebare, P., Cuu, G., Rek, J. C., Zedi, M., Kizza, T., Arinaitwe, E., Nankabirwa, J. I., Kamya, M. R., et al. (2022) · medRxiv · doi:10.1101/2022.09.20.22280170 · Cited by 6
Self-citationAhmad, H. A., Khan, H., Shahzad, M. A., Haq, Z. U., Harakeh, S., & Yousafzai, Y. M. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.10.005 · Cited by 5
Brydak, L. B., Sikora, D., Poniedziałek, B., Hallmann, E., Szymański, K., Kondratiuk, K., & Rzymski, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051733 · Cited by 5
Nedelcu, I., Jipa, R. E., Vasilescu, R., Băicuş, C., Popescu, C.-I., Manea, E., Stoichitoiu, L. E., Pinte, L., Damalan, A., Simulescu, O., et al. (2021) · Viruses · doi:10.3390/v13071244 · Cited by 6
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211
Justman, J. E., Skalland, T., Moore, A. T., Amos, C. I., Marzinke, M. A., Zangeneh, S. Z., Kelley, C. F., Singer, R. M., Mayer, S., Hirsch‐Moverman, Y., et al. (2024) · Emerging infectious diseases · doi:10.3201/eid3002.230863 · Cited by 5
O'Mahoney, C., Watt, I. N., Fiedler, S., Devenish, S. R. A., Srikanth, S., Justice, E., Dover, T., Dean, D., & Peng, C. A. (2024) · Annals of Biomedical Engineering · doi:10.1007/s10439-024-03478-0 · Cited by 6
Franchi, L., Atanasov, V. A., Stake, M., Bates, G., Osinski, K. I., Meurer, J., & Black, B. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-76946-1 · Cited by 5
Sun, Q., & Freeman, E. E. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.5172 · Cited by 4
Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona
Jehn, M., Pandit, U., Sabin, S. J., Tompkins, C., White, J., Kaleta, E., Dale, A. P., Ross, H. M., McCullough, J. M., Pepin, S., et al. (2021) · American Journal of Public Health · doi:10.2105/ajph.2021.306568 · Cited by 4
Bhuiyan, M. S., Brintz, B. J., Whitcombe, A. L., Markmann, A. J., Bartelt, L. A., Moreland, N. J., Azman, A. S., & Leung, D. T. (2022) · Epidemiology and Infection · doi:10.1017/s0950268821002764 · Cited by 4
Sero-Prevalence of Covid-19 among workers in MalaysiaPreprint
Noordin, N. M., Omar, A., Isharudin, I. H., Idris, R., Chem, Y., Sahat, I. S. M., Sengol, S., Aziz, Z. A., Lim, Z.-Z., & Lim, T. O. (2022) · medRxiv · doi:10.1101/2022.01.16.22269388 · Cited by 4
Bratcher, A. M., Kao, S. Z., Chun, K., Petropoulos, C. J., Gundlapalli, A. V., Jones, J. M., & Clarke, K. E. N. (2024) · Emerging infectious diseases · doi:10.3201/eid3011.240043 · Cited by 5
Self-citationBagala, I., Namuganga, J. F., Nayebare, P., Cuu, G., Katairo, T., Nabende, I., Gonahasa, S., Nassali, M., Tukwasibwe, S., Dorsey, G., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312554 · Cited by 5
Self-citationMizoue, T., Yamamoto, S., Tanaka, A., Oshiro, Y., Inamura, N., Konishi, M., Ozeki, M., & Ohmagari, N. (2021) · GHM Open · doi:10.35772/ghmo.2021.01030 · Cited by 3
Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
Falender, R. A., Mitchell, P., Guzman‐Cottrill, J. A., Cieslak, P. R., & Sutton, M. (2023) · Emerging infectious diseases · doi:10.3201/eid2908.230471 · Cited by 3
Whelan, M., Galipeau, Y., Habeeb, N. W.-A., Konforte, D., Hassan, M. A. E., Booth, R. A., Arnold, C. R., Langlois, M., & Pelchat, M. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad384 · Cited by 4
Cree, B., Maddux, R., Bar‐Or, A., Hartung, H., Kaur, A., Brown, E. A., Li, Y., Hu, Y., Sheffield, J. K., Silva, D. A. S., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51862 · Cited by 3
Yan, Y., Saito, K., Naito, T., Ito, K., Nojiri, S., Horiuchi, Y., Deshpande, G. A., Yokokawa, H., & Tabe, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-53656-2 · Cited by 3
Tess, B. H., Martelli, C. M. T., Alves, M. C. G. P., Cortés, F., Bernal, R. T. I., de Souza, W. V., Luna, E. J. D. A., Rodrigues, L. D. C., Nunes, M. C., Reinach, F. D. C., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309441 · Cited by 4
Metadata
- Authors
- Peluso, M. J., Takahashi, S., Hakim, J., Kelly, J. D., Torres, L., Iyer, N. S., Turcios, K., Janson, O., Munter, S. E., Thanh, C., Donatelli, J., Nixon, C. C., Hoh, R., Tai, V., Fehrman, E. A., Hernandez, Y., Spinelli, M. A., Gandhi, M., Palafox, M.-A., Vallari, A., Rodgers, M. A., Prostko, J., Hackett, J., Trinh, L., Wrin, T., Petropoulos, C. J., Chiu, C. Y., Norris, P. J., DiGermanio, C., Stone, M., Busch, M. P., Elledge, S. K., Zhou, X. X., Wells, J. A., Shu, A., Kurtz, T. W., Pak, J. E., Wu, W., Burbelo, P. D., Cohen, J. I., Rutishauser, R. L., Martin, J. N., Deeks, S. G., Henrich, T. J., Rodriguez-Barraquer, I., & Greenhouse, B.
- Affiliations
- University of California, San Francisco (US)
- Abbott (United States) (US)
- Monogram Biosciences Inc., South San Francisco, CA, USA.
- Vitalant Research Institute (US)
- Vitalant Research Institute, San Francisco, CA, USA.
- Chan Zuckerberg Biohub San Francisco (US)
- National Institutes of Health (US)
- Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
- Corresponding author
- Peluso, Michael J.
- Takahashi, Saki
- Hakim, Jill
- Henrich, Timothy J.
- Greenhouse, Bryan
- ORCID
- Peluso, Michael J.
- Takahashi, Saki
- Hakim, Jill
- Kelly, J. Daniel
- Torres, Leonel
- Iyer, Nikita S.
- Thanh, Cassandra
- Hoh, Rebecca
- Tai, Viva
- Hernandez, Yanel
- Spinelli, Matthew A.
- Gandhi, Monica
- Palafox, Mary-Ann
- Vallari, Ana
- Rodgers, Mary A.
- Petropoulos, Christos J.
- Chiu, Charles Y.
- Norris, Philip J.
- DiGermanio, Clara
- Stone, Mars
- Busch, Michael P.
- Elledge, Susanna K.
- Zhou, Xin X.
- Wells, James A.
- Shu, Albert
- Kurtz, Theodore W.
- Pak, John E.
- Wu, Wesley
- Burbelo, Peter D.
- Cohen, Jeffrey I.
- Rutishauser, Rachel L.
- Martin, Jeffrey N.
- Deeks, Steven G.
- Henrich, Timothy J.
- Rodriguez-Barraquer, Isabel
- Greenhouse, Bryan
- Venue
- Science Advances
- Published
- 2021-07-30
- Volume
- 7
- Issue
- 31
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8324059
- OpenAlex
- W3192055536
- Cited by
- 130
- References
- 29
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 18 · 2023: 23 · 2022: 52 · 2021: 26
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (T32 AI60530-12)
- National Heart, Lung, and Blood Institute (R01 HL105704, R33- 29077)
- National Institute of Allergy and Infectious Diseases (3R01AI141003-03S1, R01AI158013)
- National Institute of Dental and Craniofacial Research
- Chan Zuckerberg Biohub Investigator Fund
- MIDAS Coordination Center (MIDASNI2020)
- Instituto Nacional de Ciência e Tecnologia Midas (MIDASNI2020)
- Damon-Runyon Cancer Research Fellowship
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, antibody response, serological surveillance, disease severity, seroreversion, neutralizing antibodies, spike protein antibodies, nucleocapsid antibodies, mild infection, assay variability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.